Back to search
FDAFDA · Food and drugs·Recall number Z-3262-2024

PT301US Airvo 3 Respiratory Support Device with software version 1.2.0 and/or 1.5.1 The Airvo 3 is intended to provide high flow warmed and humidified respiratory gases for administration to spontaneously breathing infant, child, adolescent and adult patients in hospitals and sub-acute facilities.

Published October 2, 2024 · Recall initiated: August 7, 2024

Summary

FDA records medical device Class II recall Z-3262-2024, published October 2, 2024 and initiated August 7, 2024. Recalling firm: Fisher & Paykel Healthcare, Ltd.; Status: Ongoing; Reported quantity: 944 units; Lot: Model Number: PT301US UDI-DI code: 09420012466662 Lot/Serial Numbers:. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to a software issue, affected devices that are set up with High Pressure Oxygen (HPO), if the flow alignment alarm occurs, the device will deliver room air only. If this happens, a patient my experience oxygen desaturation that could lead to hypoxia.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fisher & Paykel Healthcare, Ltd.
Distributor
U.S.: AZ, CA, CO, CT, DC, FL, GA, IA, IL, KY, MA, MD, MI, MN, MO, MT, ND, NH, NJ, NV, NY, OH, OR, PA, SD, TX, UT, VA and WA. O.U.S.: Not provided
Lot
Model Number: PT301US UDI-DI code: 09420012466662 Lot/Serial Numbers:
Risk classification
Class II
Area (FDA)
device
Country
New Zealand

Related recalls

Questions about this recall

Was PT301US Airvo 3 Respiratory Support Device with software version 1.2.0 and/or 1.5.1 The Airvo 3 is intended to provide high flow warmed and humidified respiratory gases for administration to spontaneously breathing infant, child, adolescent and adult patients in hospitals and sub-acute facilities. recalled?

Yes. FDA published recall Z-3262-2024 on October 2, 2024. Reported hazard: Due to a software issue, affected devices that are set up with High Pressure Oxygen (HPO), if the flow alignment alarm occurs, the device will deliver room air only. If this happens, a patient my experience oxygen desaturation that could lead to hypoxia.

What should I do if I have this product?

Voluntary: Firm initiated · Letter